» Articles » PMID: 22476248

Infection, Mutation, and Cancer Evolution

Overview
Specialty General Medicine
Date 2012 Apr 6
PMID 22476248
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

An understanding of oncogenesis can be fostered by an integration of mechanistic studies with evolutionary considerations, which help explain why these mechanisms occur. This integration emphasizes infections and mutations as joint essential causes for many cancers. It suggests that infections may play a broader causal role in oncogenesis than has been generally appreciated. An evolutionary perspective also suggests that oncogenic viruses will tend to be transmitted by routes that provide infrequent opportunities for transmission, such as transmission by sexual and salivary contact. Such routes increase the intensity of natural selection for persistence within hosts, and molecular mechanisms for persistence often compromise critical barriers to oncogenesis, particularly cell cycle arrest, apoptosis, and a cap on the total number of divisions that a cell can undergo.

Citing Articles

Modeling cancer's ecological and evolutionary dynamics.

Bukkuri A, Pienta K, Hockett I, Austin R, Hammarlund E, Amend S Med Oncol. 2023; 40(4):109.

PMID: 36853375 PMC: 9974726. DOI: 10.1007/s12032-023-01968-0.


Searching for the Metabolic Signature of Cancer: A Review from Warburg's Time to Now.

Jacquet P, Stephanou A Biomolecules. 2022; 12(10).

PMID: 36291621 PMC: 9599674. DOI: 10.3390/biom12101412.


A Review of the Role of Oral Microbiome in the Development, Detection, and Management of Head and Neck Squamous Cell Cancers.

Burcher K, Burcher J, Inscore L, Bloomer C, Furdui C, Porosnicu M Cancers (Basel). 2022; 14(17).

PMID: 36077651 PMC: 9454796. DOI: 10.3390/cancers14174116.


DNA viruses and cancer: insights from evolutionary biology.

Pandey N Virusdisease. 2020; 31(1):1-9.

PMID: 32206692 PMC: 7085488. DOI: 10.1007/s13337-019-00563-0.


Infection as a potential cofactor in the genetic-epigenetic pathophysiology of endometriosis: a systematic review.

Koninckx P, Ussia A, Tahlak M, Adamyan L, Wattiez A, Martin D Facts Views Vis Obgyn. 2020; 11(3):209-216.

PMID: 32082526 PMC: 7020943.


References
1.
Kirk G, Mendy M, Goedert J, Merle P, Trepo C, Brechot C . Ser-249 p53 mutations in plasma DNA of patients with hepatocellular carcinoma from The Gambia. J Natl Cancer Inst. 2000; 92(2):148-53. DOI: 10.1093/jnci/92.2.148. View

2.
Knight J, Sharma N, Robertson E . Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase. Proc Natl Acad Sci U S A. 2005; 102(51):18562-6. PMC: 1317900. DOI: 10.1073/pnas.0503886102. View

3.
Yi F, Saha A, Murakami M, Kumar P, Knight J, Cai Q . Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. Virology. 2009; 388(2):236-47. PMC: 4287381. DOI: 10.1016/j.virol.2009.03.027. View

4.
Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A . The role of TP53 in Cervical carcinogenesis. Hum Mutat. 2003; 21(3):307-12. DOI: 10.1002/humu.10178. View

5.
Limpaiboon T, Pooart J, Bhattarakosol P, Niruthisard S, Chantratita W, Lulitanond V . p53 status and human papillomavirus infection in Thai women with cervical carcinoma. Southeast Asian J Trop Med Public Health. 2000; 31(1):66-71. View